Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Molecular diagnostics firm Nanosphere said that the underwriters of its recent initial public offering have exercised their over-allotment option in full to purchase an additional 1.05 million shares of Nanosphere's common stock at $14.00 per share, less underwriting discounts and commissions.
Subscribe to our email newsletter
The option was granted in connection with Nanosphere’s initial public offering of 7,000,000 shares. The closing of the sale of all 8,050,000 shares by Nanosphere to the underwriters occurred earlier today.
Credit Suisse Securities (USA) acted as the sole book-runner for the offering. Piper Jaffray & Co, Leerink Swann, and Allen & Company acted as co-managers.